Related articles:

GlycoMimetics Inc.: GlycoMimetics Reports Fourth Quarter and Year-End 2016 Results
March 01, 2017
March 1, 2017

GlycoMimetics Inc.: GlycoMimetics Reports Second Quarter 2016 Results
August 04, 2016
August 4, 2016

GlycoMimetics Inc.: GlycoMimetics to Present at Jefferies 2016 Healthcare Conference
June 02, 2016
June 2, 2016

GlycoMimetics Inc.: GlycoMimetics Reports First Quarter 2016 Results
May 04, 2016
May 4, 2016

GlycoMimetics Inc.: GlycoMimetics Appoints ImmunoGen CEO Daniel Junius to Board of Directors
March 21, 2016
March 21, 2016

GlycoMimetics Inc.: GlycoMimetics Reports Fourth Quarter and Year-End 2015 Results
February 29, 2016
February 29, 2016

GlycoMimetics Inc.: GlycoMimetics Reports Third Quarter 2015 Results
November 12, 2015
November 12, 2015

GlycoMimetics Inc.: GlycoMimetics Announces Issuance of U.S. Composition of Matter Patent for Drug Candidate GMI-1271
August 31, 2015
August 31, 2015

GlycoMimetics Inc.: GlycoMimetics Reports Second Quarter 2015 Results
August 06, 2015
August 6, 2015

GlycoMimetics Inc.: GlycoMimetics Reports First Quarter 2015 Results
May 05, 2015
May 5, 2015

GlycoMimetics Inc.: GlycoMimetics Reports Fourth Quarter and Year-End 2014 Results
March 16, 2015
March 16, 2015

GlycoMimetics Inc.: GlycoMimetics Reports Third Quarter 2014 Results
October 31, 2014
October 31, 2014

GlycoMimetics Inc.: GlycoMimetics Reports Second Quarter 2014 Results
July 31, 2014
July 31, 2014

GlycoMimetics Inc.: GlycoMimetics Appoints Mark A. Goldberg, M.D. to Board of Directors
July 10, 2014
July 10, 2014

GlycoMimetics Inc.: GlycoMimetics Announces Pricing of Initial Public Offering
January 09, 2014
January 9, 2014

Pin It on Pinterest

Share This